Needlefree Hemodialysis Connector
Designed to help protect your patients’ catheters from contamination and increased risk of catheter-related bloodstream infections (CRBSIs) during hemodialysis and apheresis applications
Use of Tego was shown to be associated with a 10-12% reduction in CRBSIs.1
Straight fluid path accommodates flow rates of > 600 mL/min.
Validated for continuous patient use for up to 7 days.
Help protect your patients’ hemodialysis catheters from contamination and minimize the risk of CRBSIs
The Tego needlefree hemodialysis connector creates a closed system when attached to the hub of a catheter to minimize contamination and help reduce the risk of CRBSIs. Tego’s saline flush option is designed to help reduce the risk of heparin-induced thrombocytopenia (HIT) and helps you minimize overall hemodialysis costs by reducing heparin use.2-3
- Straight fluid path accommodates flow rates of greater than 600 mL/min
- Remains in place during the entire hemodialysis treatment period
- Validated for continuous patient use for up to 7 days
- Silicone seal remains closed when not activated, closing the fluid path
- Use of Tego was shown to be associated with a 10-12% reduction in CRBSIs1
- Tego is a needle-free capping device which closes the end of a catheter, creating a mechanically closed system, prohibiting microbial ingress when attached to the hub of a catheter. Tego will permit access to the catheter without the use of needles, and therefore passively aid in the reduction of needlestick injuries.
- Tego's saline flush option helps to reduce risks and costs associated with heparin use.
Accessing the Fluid Path:
- When Tego is not being accessed, the silicone seal forms a swabbable barrier to bacterial ingress.
- Attaching a dialysis bloodline to Tego activates the straight internal fluid path and creates a mechanically closed system, prohibiting microbial ingress.
Attach the Tego to Patient’s Catheter
Swab the Tego Before Each Access
Access the Tego
Flush the Tego
Precautions: Device should be changed in accordance with current, recognized guidelines of IV therapy. Tego has been validated for functional and microbiological efficacy for up to seven days.
Please enter your details into the following form.
Brunelli SM, Njord L, Hunt AE, Sibbel SP. Use of the Tego needlefree connector is associated with reduced incidence of catheter-related bloodstream infections in hemodialysis patients. Int J Nephrol Renovasc Dis. 2014; 7: 131–139.
Farthing, C et al. Tego connectors reduce heparin use without affecting blood flow rate compared to traditional central venous catheter locks. American Nephrology Nurses Association 43rd National Symposium, Orlando, FL, Apr 29-May 2, 2012.
Krishnan M et al. Tego connectors reduce heparin use without affecting blood flow rate compared to traditional central venous catheter locks. American Society of Nephrology Kidney Week. Philadelphia, PA, Nov 8-11, 2011.